Skip to main content
Top
Published in: Gastric Cancer 3/2000

01-12-2000 | Case report

Benign gastric carcinoid tumor with hypergastrinemia followed up for 12 years

Authors: Kimiyuki Hori, Hirokazu Fukui, Johji Imura, Takane Kojima, Mikio Fujita, Hitoski Kawamata, Tsutomu Chiba, Takahiro Fujimori

Published in: Gastric Cancer | Issue 3/2000

Login to get access
Metadata
Title
Benign gastric carcinoid tumor with hypergastrinemia followed up for 12 years
Authors
Kimiyuki Hori
Hirokazu Fukui
Johji Imura
Takane Kojima
Mikio Fujita
Hitoski Kawamata
Tsutomu Chiba
Takahiro Fujimori
Publication date
01-12-2000
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2000
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/PL00011712

Other articles of this Issue 3/2000

Gastric Cancer 3/2000 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine